SAN FRANCISCO, May 8, 2017 /PRNewswire/ --
The global respiratory diseases testing market is expectedto reach USD 6.7 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the market.
Browse full research report with TOC on "Respiratory Disease Testing/Diagnostics Market Analysis By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use (Hospitals, Physicians Clinic, Clinical Laboratories, Ambulatory Services), And Segment Forecasts, 2014 - 2025 " at: http://www.grandviewresearch.com/industry-analysis/respiratory-disease-testing-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the respiratory disease testing/diagnostics market by product, end-use and regions.
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...
Unintended pregnancies are very common these days, and so one in about four pregnant women go for ...View All